What: A feature by States Newsroom examines how abortion bans are influencing women’s family planning decisions, as many worry they won’t receive proper care if they have children.
Key line: [Details not provided].
Source: Tennessee Lookout.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
A review on how abortion rates increased after Roe v. Wade was overturned.
Breast cancer mortality decline stalled for women over 74.
Postpartum depression tied to brain changes after childbirth.
The Texas attorney general announced the arrest of a midwife accused of providing abortions despite the state’s ban.
A study from Intermountain Health finds heart outcome disparities between men and women are decreasing — but gaps in care remain.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
A deep dive on the ethical implications of working with human embryos.
Study links heavy menstrual bleeding during menopause to increased fatigue.
Research compares telehealth patients seeking abortion pills for future use to those seeking them for current pregnancies.
New report calls women’s health a $360B ‘ghost market’ full of unmet needs across menopause, sexual health, aging, and more.
Study explores gene activation in women’s brains that may slow cognitive decline.
Texas Democrats push for maternal mortality transparency and tracking.
KFF explains that Medicaid already has mechanisms in place to prevent fraud and waste, despite recent rhetoric.
Exploring new techniques to delay menopause, including ovarian freezing.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
Study links higher menopausal symptom burden to dementia markers.
A study found the highest increase in prescription stimulant use among women aged 35-64, despite low rates of abuse.
A systematic review found laser treatments improve menopause symptoms but do not enhance tissue quality.
The Wall Street Journal examines why women in their 30s and 40s are opting for facelifts earlier than before.